与序贯唑来膦酸和地诺单抗治疗相关的非典型股骨骨折：一例报告 - Suppr

Suppr

超能文献

Atypical femoral fracture associated with sequential zoledronic acid and denosumab therapy: a case report.

作者信息

Zhang Bo, Zhang Haijun, Chen Qiaojie, Chen Yang

机构信息

Department of Orthopedics, Ningbo No. 2 Hospital, Ningbo, 315010, China.

出版信息

Arch Osteoporos. 2025 Jun 3;20(1):69. doi: 10.1007/s11657-025-01558-9.

DOI:10.1007/s11657-025-01558-9

PMID:40459674

Abstract

摘要

相似文献

Atypical femoral fracture associated with sequential zoledronic acid and denosumab therapy: a case report.与序贯唑来膦酸和地诺单抗治疗相关的非典型股骨骨折：一例报告

Arch Osteoporos. 2025 Jun 3;20(1):69. doi: 10.1007/s11657-025-01558-9.

Atypical femoral fracture in a metastatic bone disease patient six months after discontinuation of denosumab received sequentially to previous bisphosphonate therapy - A case report.唑来膦酸序贯治疗后发生的转移性骨病患者停用地舒单抗 6 个月后发生非典型股骨骨折：1 例报告

J Musculoskelet Neuronal Interact. 2021 Sep 1;21(3):429-433.

Bilateral atypical femur fracture in a patient with breast cancer taking zoledronic acid and denosumab: A case report.一名正在服用唑来膦酸和地诺单抗的乳腺癌患者发生双侧非典型股骨骨折：病例报告。

Mod Rheumatol Case Rep. 2025 Jan 16;9(1):41-45. doi: 10.1093/mrcr/rxae059.

Cost-effectiveness of zoledronic acid compared with sequential denosumab/alendronate for older osteoporotic women in Japan.唑来膦酸与序贯地诺单抗/阿仑膦酸钠治疗日本老年骨质疏松症女性的成本效益比较。

Arch Osteoporos. 2021 Jul 15;16(1):113. doi: 10.1007/s11657-021-00956-z.

Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.40 岁及以上成年人在初级保健中进行脆性骨折一级预防的筛查：筛查和治疗效果及可接受性以及风险预测工具准确性的系统评价。

Syst Rev. 2023 Mar 21;12(1):51. doi: 10.1186/s13643-023-02181-w.

Atypical femoral fracture in patients with bone metastasis receiving denosumab therapy: a retrospective study and systematic review.接受地舒单抗治疗的骨转移患者的非典型股骨骨折：一项回顾性研究和系统评价。

BMC Cancer. 2019 Oct 22;19(1):980. doi: 10.1186/s12885-019-6236-6.

Atypical femoral fracture in a multiple myeloma patient undergoing treatment with denosumab: A case report and literature review.一名接受地诺单抗治疗的多发性骨髓瘤患者发生非典型股骨骨折：病例报告及文献综述

Int J Surg Case Rep. 2023 Jul;108:108456. doi: 10.1016/j.ijscr.2023.108456. Epub 2023 Jul 3.

Multiple Stress Fractures in a Young Cancer Patient on Long-Term Zoledronic Acid: A Case Report and Review of Literature.一名长期使用唑来膦酸的年轻癌症患者发生多处应力性骨折：病例报告及文献综述

Cureus. 2024 Sep 23;16(9):e69999. doi: 10.7759/cureus.69999. eCollection 2024 Sep.

Cost-Effectiveness of Sequential Denosumab/Zoledronic Acid Compared With Zoledronic Acid Monotherapy for Postmenopausal Osteoporotic Women in China.在中国，与唑来膦酸单药治疗相比，序贯使用地诺单抗/唑来膦酸治疗绝经后骨质疏松症女性的成本效益分析

Front Pharmacol. 2022 Mar 18;13:816248. doi: 10.3389/fphar.2022.816248. eCollection 2022.

Denosumab-associated Periprosthetic Atypical Femur Fracture: A Case Report.地诺单抗相关的人工关节周围非典型股骨骨折：一例报告

J Orthop Case Rep. 2023 Sep;13(9):29-32. doi: 10.13107/jocr.2023.v13.i09.3864.

本文引用的文献

Denosumab for osteoporosis treatment: when, how, for whom, and for how long. A pragmatical approach.地诺单抗用于骨质疏松症治疗：何时、如何使用、适用于何人以及使用多久。一种实用方法。

Aging Clin Exp Res. 2025 Mar 8;37(1):70. doi: 10.1007/s40520-025-02991-z.

The effect of teriparatide on fracture healing after atypical femoral fracture: A systematic review and meta-analysis.特立帕肽对非典型股骨骨折愈合的影响：系统评价和荟萃分析。

Osteoporos Int. 2023 Aug;34(8):1323-1334. doi: 10.1007/s00198-023-06768-w. Epub 2023 Apr 25.

Denosumab in the Treatment of Osteoporosis: 10 Years Later: A Narrative Review.地舒单抗治疗骨质疏松症：10 年后：叙事性综述。

Adv Ther. 2022 Jan;39(1):58-74. doi: 10.1007/s12325-021-01936-y. Epub 2021 Nov 11.

Atypical Femur Fracture Risk versus Fragility Fracture Prevention with Bisphosphonates.非典型股骨骨折风险与双膦酸盐预防脆性骨折。

N Engl J Med. 2020 Aug 20;383(8):743-753. doi: 10.1056/NEJMoa1916525.

Medical Management of Patients After Atypical Femur Fractures: a Systematic Review and Recommendations From the European Calcified Tissue Society.非典型股骨骨折患者的医学管理：来自欧洲钙化组织协会的系统评价和建议。

J Clin Endocrinol Metab. 2020 May 1;105(5):1682-99. doi: 10.1210/clinem/dgz295.

10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension.10 年地舒单抗治疗绝经后骨质疏松症妇女：来自 3 期随机 FREEDOM 试验和开放标签扩展的结果。

Lancet Diabetes Endocrinol. 2017 Jul;5(7):513-523. doi: 10.1016/S2213-8587(17)30138-9. Epub 2017 May 22.

Bisphosphonates and atypical femoral fractures.双膦酸盐类药物与非典型股骨骨折。

Curr Opin Endocrinol Diabetes Obes. 2016 Dec;23(6):430-434. doi: 10.1097/MED.0000000000000287.

Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial.地诺单抗与特立帕肽在绝经后骨质疏松症中的转换（DATA-Switch研究）：一项随机对照试验的扩展

Lancet. 2015 Sep 19;386(9999):1147-55. doi: 10.1016/S0140-6736(15)61120-5. Epub 2015 Jul 2.

Bilateral atypical femoral fractures in a patient prescribed denosumab - a case report.患者应用地舒单抗后发生双侧非典型股骨骨折：病例报告。

Bone. 2014 Apr;61:44-7. doi: 10.1016/j.bone.2013.12.027. Epub 2013 Dec 31.

Atypical femoral fractures: a review of the literature.非典型股骨骨折：文献回顾。

Curr Osteoporos Rep. 2013 Sep;11(3):179-87. doi: 10.1007/s11914-013-0167-y.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验